Phyllis Gotlib Sells 4,781 Shares of American Well Co. (NYSE:AMWL) Stock

American Well Co. (NYSE:AMWL) insider Phyllis Gotlib sold 4,781 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $8.80, for a total value of $42,072.80. Following the completion of the sale, the insider now directly owns 147,998 shares in the company, valued at approximately $1,302,382.40. This represents a 3.13 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Phyllis Gotlib also recently made the following trade(s):

• On Monday, February 3rd, Phyllis Gotlib sold 299 shares of American Well stock. The shares were sold at an average price of $10.51, for a total transaction of $3,142.49.

American Well Stock Up 0.3 %

AMWL traded up $0.03 during trading on Wednesday, hitting $8.73. The company’s stock had a trading volume of 56,633 shares, compared to its average volume of 76,956. American Well Co. has a one year low of $5.00 and a one year high of $21.60. The business’s 50 day simple moving average is $9.84 and its 200-day simple moving average is $9.34. The firm has a market cap of $136.23 million, a PE ratio of -0.62 and a beta of 1.18.

American Well (NYSE:AMWL) last released its earnings results on Wednesday, February 12th. The company reported ($2.77) EPS for the quarter, topping analysts’ consensus estimates of ($3.04) by $0.27. American Well had a negative net margin of 81.83% and a negative return on equity of 56.73%. Equities research analysts expect that American Well Co. will post -9.34 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently weighed in on AMWL. Morgan Stanley reduced their price target on shares of American Well from $20.00 to $10.50 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Wells Fargo & Company upgraded American Well from an “equal weight” rating to an “overweight” rating and set a $15.00 price target for the company in a research note on Monday, January 13th. Stifel Nicolaus lifted their price objective on American Well from $9.00 to $10.00 and gave the stock a “hold” rating in a report on Thursday, February 13th. Truist Financial upped their target price on shares of American Well from $10.00 to $12.00 and gave the company a “hold” rating in a research note on Friday, February 14th. Finally, Needham & Company LLC reissued a “hold” rating on shares of American Well in a report on Thursday, February 13th. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $11.90.

Hedge Funds Weigh In On American Well

Several large investors have recently made changes to their positions in the business. BNP Paribas Financial Markets bought a new position in American Well in the 3rd quarter worth approximately $95,000. HighTower Advisors LLC purchased a new position in American Well during the third quarter valued at $355,000. Compagnie Lombard Odier SCmA bought a new stake in American Well in the 4th quarter valued at $45,000. PDT Partners LLC purchased a new stake in American Well in the 3rd quarter worth $107,000. Finally, Walleye Capital LLC bought a new position in shares of American Well during the 3rd quarter valued at about $167,000. 56.05% of the stock is currently owned by hedge funds and other institutional investors.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.